×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Biohaven Ltd. (BHVN) NEW YORK STOCK EXCHANGE INC.

$38.09 0.14 (0.37%)

Market Cap: $3.36B

As of 07/12/24 04:00 PM EDT. Market closed.

(BHVN)

Biohaven Ltd. (BHVN)
NEW YORK STOCK EXCHANGE INC.

$38.09
0.14 (0.37%)

Market Cap: $3.36B

As of 07/12/24 04:00 PM EDT. Market closed.

Add to Portfolio

Biohaven is a biopharmaceutical company dedicated to developing and commercializing life-changing treatments in immunology, neuroscience, and oncology. Their innovative portfolio includes treatments for epilepsy, mood disorders, migraine, neuropathic pain, neuroinflammatory disorders, OCD, spinal muscular atrophy, and cancer using various drug development platforms. Through their Glutamate ... read more

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO Compensation (Base)
$500,000
CEO Compensation (Total)
$7.85M
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO Compensation (Base)
$500,000
CEO Compensation (Total)
$7.85M
URL
Address
.
PRICE CHART FOR BIOHAVEN LTD
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$38
Previous Close
$37.95
Days Range
$37.70 - $39.03
52 week range
$16.45 - $62.21
Volume
983,278
Avg. Volume (30 days)
1,273,005
Market Cap
$3.36B
Dividend Yield
-
P/E
-
Shares Outstanding
88,291,909
Open
$38
Previous Close
$37.95
Days Range
$37.70 - $39.03
52 week range
$16.45 - $62.21
Volume
983,278
Avg. Volume (30 days)
1,273,005
Market Cap
$3.36B
Dividend Yield
-
P/E
-
Shares Outstanding
88,291,909
FINANCIAL STATEMENTS FOR BIOHAVEN LTD
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR BIOHAVEN LTD
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Car BruceChief Scientific OfficerJun 17, 2024 Buy$33.5830,0001,007,49030,000Jun 20, 2024, 07:30 AM
CHILDS JOHN WDirectorMay 30, 2024 Buy$35.5828,000996,2402,311,341May 31, 2024, 09:04 AM
Bailey GregoryDirectorMay 13, 2024 Buy$34.1915,000512,8771,615,071May 15, 2024, 07:31 AM
CHILDS JOHN WDirectorMay 13, 2024 Buy$35.1728,5001,002,4702,283,341May 14, 2024, 07:30 AM
Bailey GregoryDirectorApr 24, 2024 Buy$39.1825,503999,1691,600,071Apr 25, 2024, 07:32 AM
Bailey GregoryDirectorApr 22, 2024 Buy$41.0048,7801,999,9801,574,568Apr 23, 2024, 07:54 AM
CHILDS JOHN WDirectorApr 22, 2024 Buy$41.0073,1702,999,9702,254,841Apr 23, 2024, 07:54 AM
CHILDS JOHN WDirectorApr 22, 2024 Buy$41.0097,5603,999,9604,096,512Apr 23, 2024, 07:54 AM
CHILDS JOHN WDirectorApr 22, 2024 Buy$41.0024,3911,000,03124,391Apr 23, 2024, 07:54 AM
Coric VladChief Executive OfficerApr 22, 2024 Buy$41.00121,9514,999,9911,788,417Apr 23, 2024, 07:54 AM
Antonijevic IrinaDirectorDec 29, 2023 Sale$41.7911,000459,6622,535Dec 29, 2023, 06:25 PM
CHILDS JOHN WDirectorOct 05, 2023 Buy$22.00136,5453,003,9902,111,663Oct 10, 2023, 07:07 PM
CHILDS JOHN WDirectorOct 05, 2023 Buy$22.00318,0006,996,0003,998,952Oct 10, 2023, 07:07 PM
Coric VladChief Executive OfficerOct 05, 2023 Buy$22.00113,6372,500,0141,657,031Oct 10, 2023, 07:17 AM
Coric VladChief Executive OfficerOct 05, 2023 Buy$22.00340,9087,499,976833,120Oct 10, 2023, 07:17 AM
Buten MatthewChief Financial OfficerOct 05, 2023 Buy$22.0022,727499,994189,380Oct 06, 2023, 07:38 AM
Bailey GregoryDirectorOct 04, 2023 Buy$22.5717,817402,0941,525,788Oct 06, 2023, 07:37 AM
CHILDS JOHN WDirectorAug 30, 2023 Buy$18.4450,000922,1801,975,118Aug 31, 2023, 08:56 AM
CHILDS JOHN WDirectorAug 04, 2023 Buy$19.78100,0001,978,4301,925,118Aug 07, 2023, 07:29 AM
CHILDS JOHN WDirectorOct 25, 2022 Buy$10.501,328,86713,953,1041,825,118Mar 22, 2023, 06:07 PM
CHILDS JOHN WDirectorOct 25, 2022 Buy$10.502,380,95224,999,9963,680,952Mar 22, 2023, 06:07 PM
Coric VladChief Executive OfficerOct 31, 2022 Buy$15.9725,800411,9951,543,394Nov 01, 2022, 07:34 AM
Coric VladChief Executive OfficerOct 28, 2022 Buy$14.82100,0001,482,420109,565Oct 31, 2022, 07:52 AM
Coric VladChief Executive OfficerOct 28, 2022 Buy$14.8741,930623,3521,517,594Oct 31, 2022, 07:52 AM
Bailey GregoryDirectorOct 25, 2022 Buy$10.50200,0002,100,0001,507,971Oct 26, 2022, 06:22 PM
Coric VladChief Executive OfficerOct 25, 2022 Buy$10.50853,3808,960,4901,475,664Oct 26, 2022, 06:22 PM
CHILDS JOHN WDirectorOct 25, 2022 Buy$10.503,900,00040,950,0005,691,251Oct 26, 2022, 06:22 PM
Buten MatthewChief Financial OfficerOct 25, 2022 Buy$10.50142,8571,499,999166,653Oct 26, 2022, 06:21 PM
GREGORY JULIA PDirectorOct 25, 2022 Buy$10.509,52399,99225,665Oct 26, 2022, 06:19 PM
HUGIN ROBERT JDirectorOct 03, 2022 Option Exercise$7.5012,95997,19312,959Oct 12, 2022, 06:31 PM
Heffernan Michael ThomasDirectorOct 03, 2022 Option Exercise$7.509,69972,74315,178Oct 12, 2022, 06:31 PM
Coric VladChief Executive OfficerOct 05, 2022 Buy$10.31242,6932,502,096399,443Oct 06, 2022, 07:20 PM
Coric VladChief Executive OfficerOct 05, 2022 Buy$10.31243,0822,507,329492,212Oct 06, 2022, 07:20 PM
CHILDS JOHN WDirectorOct 05, 2022 Buy$8.98274,1412,461,1721,791,251Oct 05, 2022, 09:44 PM
Heffernan Michael ThomasDirectorOct 03, 2022 Option Exercise$7.505,50741,30319,370Oct 05, 2022, 05:42 PM
Heffernan Michael ThomasDirectorOct 03, 2022 Option Exercise$3.1323,21772,72924,877Oct 05, 2022, 05:42 PM
Gentile KimberlySVP, Clinical OperationsOct 03, 2022 Option Exercise$7.0037,492262,44495,969Oct 05, 2022, 05:42 PM
Gentile KimberlySVP, Clinical OperationsOct 03, 2022 Option Exercise$2.43115,510281,160133,461Oct 05, 2022, 05:42 PM
Mehta KishanDirectorOct 03, 2022 Option Exercise$7.0011,71682,01222,662Oct 05, 2022, 05:39 PM
Mehta KishanDirectorOct 03, 2022 Option Exercise$3.1228,12187,86034,378Oct 05, 2022, 05:39 PM
GREGORY JULIA PDirectorOct 03, 2022 Option Exercise$7.5011,97589,81316,142Oct 05, 2022, 05:39 PM
GREGORY JULIA PDirectorOct 03, 2022 Option Exercise$3.1928,11789,79928,117Oct 05, 2022, 05:39 PM
CHILDS JOHN WDirectorOct 03, 2022 Option Exercise$7.505,50741,3031,522,110Oct 05, 2022, 05:37 PM
CHILDS JOHN WDirectorOct 03, 2022 Option Exercise$4.0810,11741,2891,527,617Oct 05, 2022, 05:37 PM
HUGIN ROBERT JDirectorOct 03, 2022 Option Exercise$7.503,26324,47319,486Oct 05, 2022, 05:37 PM
HUGIN ROBERT JDirectorOct 03, 2022 Option Exercise$3.7519,59173,40622,749Oct 05, 2022, 05:37 PM
Buten MatthewChief Financial OfficerOct 03, 2022 Option Exercise$7.5011,04282,81523,796Oct 05, 2022, 05:36 PM
Buten MatthewChief Financial OfficerOct 03, 2022 Option Exercise$6.3713,00082,81034,838Oct 05, 2022, 05:36 PM
Bailey GregoryDirectorOct 03, 2022 Option Exercise$7.5011,97589,8131,307,971Oct 05, 2022, 05:35 PM
Bailey GregoryDirectorOct 03, 2022 Option Exercise$3.1928,11789,7991,319,946Oct 05, 2022, 05:35 PM
Coric VladChief Executive OfficerOct 03, 2022 Option Exercise$7.50115,940869,5501,037,729Oct 05, 2022, 05:33 PM
Coric VladChief Executive OfficerOct 03, 2022 Option Exercise$1.48586,249869,4941,153,669Oct 05, 2022, 05:33 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Car BruceChief Scientific Officer06/17/20241,007,490
CHILDS JOHN WDirector05/30/2024996,240
Bailey GregoryDirector05/13/2024512,877
CHILDS JOHN WDirector05/13/20241,002,470
Bailey GregoryDirector04/24/2024999,169
Bailey GregoryDirector04/22/20241,999,980
CHILDS JOHN WDirector04/22/20242,999,970
CHILDS JOHN WDirector04/22/20243,999,960
CHILDS JOHN WDirector04/22/20241,000,031
Coric VladChief Executive Officer04/22/20244,999,991
Antonijevic IrinaDirector12/29/2023459,662
CHILDS JOHN WDirector10/05/20233,003,990
CHILDS JOHN WDirector10/05/20236,996,000
Coric VladChief Executive Officer10/05/20232,500,014
Coric VladChief Executive Officer10/05/20237,499,976
Buten MatthewChief Financial Officer10/05/2023499,994
Bailey GregoryDirector10/04/2023402,094
CHILDS JOHN WDirector08/30/2023922,180
CHILDS JOHN WDirector08/04/20231,978,430
CHILDS JOHN WDirector10/25/202213,953,104
CHILDS JOHN WDirector10/25/202224,999,996
Coric VladChief Executive Officer10/31/2022411,995
Coric VladChief Executive Officer10/28/20221,482,420
Coric VladChief Executive Officer10/28/2022623,352
Bailey GregoryDirector10/25/20222,100,000
Coric VladChief Executive Officer10/25/20228,960,490
CHILDS JOHN WDirector10/25/202240,950,000
Buten MatthewChief Financial Officer10/25/20221,499,999
GREGORY JULIA PDirector10/25/202299,992
HUGIN ROBERT JDirector10/03/202297,193
Heffernan Michael ThomasDirector10/03/202272,743
Coric VladChief Executive Officer10/05/20222,502,096
Coric VladChief Executive Officer10/05/20222,507,329
CHILDS JOHN WDirector10/05/20222,461,172
Heffernan Michael ThomasDirector10/03/202241,303
Heffernan Michael ThomasDirector10/03/202272,729
Gentile KimberlySVP, Clinical Operations10/03/2022262,444
Gentile KimberlySVP, Clinical Operations10/03/2022281,160
Mehta KishanDirector10/03/202282,012
Mehta KishanDirector10/03/202287,860
GREGORY JULIA PDirector10/03/202289,813
GREGORY JULIA PDirector10/03/202289,799
CHILDS JOHN WDirector10/03/202241,303
CHILDS JOHN WDirector10/03/202241,289
HUGIN ROBERT JDirector10/03/202224,473
HUGIN ROBERT JDirector10/03/202273,406
Buten MatthewChief Financial Officer10/03/202282,815
Buten MatthewChief Financial Officer10/03/202282,810
Bailey GregoryDirector10/03/202289,813
Bailey GregoryDirector10/03/202289,799
Coric VladChief Executive Officer10/03/2022869,550
Coric VladChief Executive Officer10/03/2022869,494
Load More Insider Transactions
FUNDS WITH A POSITION IN BIOHAVEN LTD
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.5,722,9550.00729%-0.69%Other
SUVRETTA CAPITAL MANAGEMENT, LLC4,003,0468.13%-12.46%Growth At A Reasonable Price
ADAGE CAPITAL PARTNERS GP, L.L.C.1,964,0080.2%-2.8%Other
GEODE CAPITAL MANAGEMENT, LLC1,481,0280.00749%3.83%Other
HOLOCENE ADVISORS, LP1,372,7260.28%-4.76%Growth At A Reasonable Price
FARALLON CAPITAL MANAGEMENT LLC799,0000.2%6.53%Event Driven, Value
CAPITAL WORLD INVESTORS420,9500.00381%No changeGrowth At A Reasonable Price
DRIEHAUS CAPITAL MANAGEMENT LLC280,3020.15%-25.3%Growth
D. E. SHAW & CO., INC.256,3320.01%22.13%Other
CANDRIAM S.C.A.100,0000.03%NewOther
GABELLI FUNDS LLC26,0000.01%No changeEvent Driven, Growth, Activists
OCONNOR, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS (LLC)23,000 (Call)0.0079%NewValue
TUDOR INVESTMENT CORP ET AL21,6400.00753%151.86%Event Driven, Other
AQR CAPITAL MANAGEMENT LLC16,2600.00151%58.88%Other
HARVEST MANAGEMENT LLC13,8500.51%-8.28%Event Driven
CHANGE IN SHARES OUTSTANDING FOR BIOHAVEN LTD
STOCK BUYBACKS FOR BIOHAVEN LTD
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
03/31/2024
12/31/2023
1.97%
1Q
03/31/2024
09/30/2023
19.44%
2Q
03/31/2024
06/30/2023
19.57%
3Q
03/31/2024
03/31/2023
19.64%
4Q
03/31/2024
12/31/2022
82.39%
5Q
Load More

Period of Report: 03/31/2024

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
12/31/2023
1.97%
1Q
09/30/2023
19.44%
2Q
06/30/2023
19.57%
3Q
03/31/2023
19.64%
4Q
12/31/2022
82.39%
5Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR BIOHAVEN LTD
LOADING...